Enanta Pharmaceuticals reported $-33408000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acorda Therapeutics ACOR:US $ -28.7M 9.15M
Anika Therapeutics ANIK:US $ 9.13M 7.92M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Clovis Oncology CLVS:US $ -66.45M 0.04M
Enanta Pharmaceuticals ENTA:US $ -33.41M 4.25M
GlaxoSmithKline GSK:LN 1482M 225M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Insmed INSM:US $ -116699000 25.3M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Johnson & Johnson JNJ:US $ 7776M 515M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Novavax NVAX:US $ -348.77M 129.07M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Vital Therapies VTL:US $ -17.93M 16.6M
YTE INCY:US $ 199.6M 31.06M